Sign Up to Receive the Latest Trading Tips and News from Prosper

    March 1, 2019

    European Regulators Give A Helping Hand To Lexicon Pharmaceuticals

    Lexicon Pharmaceuticals (LXRX) rallied strongly today after the European Medicines Agency’s Committee for Medicinal Product for Human Use gave LXRX’s Zynquista a positive mention. Zynquista is a joint development between Lexicon and Sanofi. Zynquista’s application for approval in the United States and Europe has been accepted and is currently under review. Here’s a recap.

    Read Article